AzarGen

AzarGen is a biotechnology company that utilizes advanced genetic engineering and synthetic biology techniques to express high-value biopharmaceutical compounds. Our focus is on leveraging plants as bioreactors to develop a pipeline of novel and patentable compounds, with a particular emphasis on complex therapeutic proteins.AzarGen has demonstrated the feasibility of its plant-based expression platform through a candidate recombinant human therapeutic protein. AzarGen's products hold promise for improving the survival rates of premature infants in both developed and developing countries, offering higher clinical efficacy and lower costs.